These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19191866)

  • 1. Anti-thymocyte globulin therapy induced a spurious increase of fibrinogen degradation products in hypoplastic myelodysplastic syndrome.
    Yahata Y; Isobe Y; Sasaki M; Oshimi K; Sugimoto K
    Eur J Haematol; 2009 May; 82(5):404. PubMed ID: 19191866
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Kim DH; Hong J; Shin DY; Kim I; Yoon SS; Bang SM; Lee JO; Lee JY; Kim SA; Byun JM; Koh Y
    Br J Haematol; 2024 Jul; 205(1):356-359. PubMed ID: 38699798
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.
    Orimoto M; Maeda M; Cai LZ; Hayakawa J; Ueda T; Migita M; Asano T
    Med Pediatr Oncol; 2003 May; 40(5):334-5. PubMed ID: 12652627
    [No Abstract]   [Full Text] [Related]  

  • 4. Tanned red cell haemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products.
    Kings GL; Stoodley KD
    Med Lab Sci; 1980 Oct; 37(4):317-22. PubMed ID: 7207041
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rabbit anti-thymocyte globulin, the cause of false-positive results in the microlymphocytotoxicity test?].
    Prazák J; Hrabánek J; Korínková P
    Cas Lek Cesk; 1989 Jan; 128(3):90-2. PubMed ID: 2785854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction.
    Komrokji RS; Mailloux AW; Chen DT; Sekeres MA; Paquette R; Fulp WJ; Sugimori C; Paleveda-Pena J; Maciejewski JP; List AF; Epling-Burnette PK
    Haematologica; 2014 Jul; 99(7):1176-83. PubMed ID: 24488560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cyclosporine concentrations in the absence of cyclosporine administration.
    Peter A; Shipkova M; Wieland E; Schleicher E; Müller I
    Clin Chem; 2011 May; 57(5):670-3. PubMed ID: 21527652
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Quantitative determination of fibrinogen-fibrin degradation products by viro-immunoassay.
    Lederman S; Rimon A
    Isr J Med Sci; 1975 Dec; 11(12):1395. PubMed ID: 1218992
    [No Abstract]   [Full Text] [Related]  

  • 9. Elimination of false-positive Histoplasma antigenemia caused by human anti-rabbit antibodies in the second-generation Histoplasma antigen assay.
    Wheat LJ; Connolly P; Durkin M; Book BK; Pescovitz MD
    Transpl Infect Dis; 2006 Dec; 8(4):219-21. PubMed ID: 17116135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False increase in C-reactive protein attributable to heterophilic antibodies in two renal transplant patients treated with rabbit antilymphocyte globulin.
    Benoist JF; Orbach D; Biou D
    Clin Chem; 1998 Sep; 44(9):1980-5. PubMed ID: 9732987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive serum chromogranin A assay due to heterophile antibody interference.
    Giovanella L; Ceriani L; Lumastro C; Ghelfo A
    Clin Chim Acta; 2007 Apr; 379(1-2):171-2. PubMed ID: 17240364
    [No Abstract]   [Full Text] [Related]  

  • 12. [Persistent elevation of D-dimer in the postpartum].
    González García ME; Arias Miranda IM; Cepeda Piorno J; Fernández Alvarez C
    Med Clin (Barc); 2008 Oct; 131(12):478. PubMed ID: 18928742
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating patients of myelodysplastic syndrome with antithymocytic globulin--should we be more selective?
    Madkaikar M; Ghosh K
    Blood; 2003 Nov; 102(10):3851-2; author reply 3852. PubMed ID: 14597610
    [No Abstract]   [Full Text] [Related]  

  • 14. False-positive D-dimer result in a latex-enhanced immunoassay caused by interfering human anti-mouse antibodies.
    Robier C; Edler E; Klescher D; Neubauer M
    Clin Chem Lab Med; 2014 Nov; 52(11):e253-5. PubMed ID: 24897407
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum fibrinogen degradation products in various surgical conditions].
    Piecuch T; Muzała-Bogdan B
    Wiad Lek; 1982 Jun; 35(7-8):473-8. PubMed ID: 7123938
    [No Abstract]   [Full Text] [Related]  

  • 16. False-elevated serum tryptase assay result caused by heterophilic antibodies.
    van Toorenenbergen AW; van Daele PL; Boonstra JG
    J Allergy Clin Immunol; 2005 Nov; 116(5):1159-60. PubMed ID: 16275392
    [No Abstract]   [Full Text] [Related]  

  • 17. A Case of False Elevation of D-Dimer and Elimination Methods.
    Yu D; Tong H
    Clin Lab; 2024 Jun; 70(6):. PubMed ID: 38868870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of D-dimer levels from heterophilic antibody in COVID-19: A serious concern in treatment and follow-up of patients.
    Ozbalci D; Doguc DK; Yilmaz G; Ozturk O; Sirin FB; Akcam FZ
    Int J Lab Hematol; 2022 Feb; 44(1):e13-e16. PubMed ID: 34191392
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypocellular myelodysplasia.
    Sloand EM
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):347-60. PubMed ID: 19327588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What makes D-dimer assays suspicious-heterophilic antibodies?
    Wu Y; Xiao YX; Huang TY; Zhang XY; Zhou HB; Zhang XX; Wu YE
    J Clin Lab Anal; 2019 Feb; 33(2):e22687. PubMed ID: 30320416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.